Mission Creek Capital Partners, Inc. Gilead Sciences, Inc. Transaction History
Mission Creek Capital Partners, Inc.
- $452 Million
- Q1 2025
A detailed history of Mission Creek Capital Partners, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mission Creek Capital Partners, Inc. holds 1,886 shares of GILD stock, worth $205,743. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,886
Previous 3,045
38.06%
Holding current value
$205,743
Previous $281,000
24.91%
% of portfolio
0.05%
Previous 0.06%
Shares
21 transactions
Others Institutions Holding GILD
# of Institutions
2,285Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.8 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.49 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.96 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.84 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $137B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...